scispace - formally typeset
F

Frederick Klauschen

Researcher at Humboldt University of Berlin

Publications -  238
Citations -  17312

Frederick Klauschen is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 45, co-authored 170 publications receiving 12451 citations. Previous affiliations of Frederick Klauschen include Charité & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Morphological and molecular breast cancer profiling through explainable machine learning

TL;DR: An explainable machine-learning approach for the integrated profiling of morphological, molecular and clinical features from breast cancer histology allows for the robust detection of cancer cells and tumour-infiltrating lymphocytes in histological images, and allows assessment of the link between morphological and molecular cancer properties.
Journal ArticleDOI

Epidermal γδ T cells originate from yolk sac hematopoiesis and clonally self-renew in the adult.

TL;DR: DETCs resemble LCs concerning their maintenance, replenishment mechanisms, and hematopoietic development, suggesting that the epidermal microenvironment exerts a lineage-independent influence on the initial seeding and homeostatic maintenance of its resident immune cells.
Journal ArticleDOI

Subgroup-specific immune and stromal microenvironment in medulloblastoma.

TL;DR: A mild, but subgroup-specific infiltration of immune cells in medulloblastoma is suggested, indicating distinct types of local tumor immunosuppression.
Journal ArticleDOI

Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatment.

TL;DR: POLE EDMs do not appear to define an entirely new clinically distinct disease entity in CRC but may have prognostic or predictive implications in CRC subgroups, whose significance remains to be investigated in future studies.
Journal ArticleDOI

Who is at risk for diagnostic discrepancies? Comparison of pre- and postmortal diagnoses in 1800 patients of 3 medical decades in East and West Berlin.

TL;DR: A well-powered analysis revealed a significant rate of class-I-discrepancies indicating that autopsies are still of value, and identified risk profiles may aid both pathologists and clinicians to identify patients at increased risk for a discrepant diagnosis and possibly suboptimal treatment intra vitam.